In this study, we demonstrated the use of CA9 and CD147 in combination as effective antigens for capturing CTCs in RCC patients with higher efficacy and sensitivity than the conventional EpCAM-based detection, suggesting the translational potential of our method for future development of CTC detection technologies for clinical applications to benefit RCC patients. Here, BSG is linked to renal cell carcinoma.